AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
DAPSONE
7 registrations across 3 African markets— 7 active
Markets with DAPSONE
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| A-LENNON DAPSONE 100 mg | 🇿🇦South Africa | Pharmacare Limited û Woodmead | active | Jan 1900 |
| DAPSONE | 🇿🇦South Africa | Pharmacare Limited û Woodmead | active | Jan 1900 |
| Dapsone Tablet 100mg Tablet | 🌍WW | Everest Life Sciences LLC | active | — |
| DAPSONE ORAL SOLID
ORDINARY TABLETS | 🇺🇬Uganda | GITTOES PHARMACEUTICA LS LIMITED | active | — |
| DAPSONE ORAL SOLID
ORDINARY
TABLETS | 🇺🇬Uganda | GITTOES PHARMACEUTICA LS LIMITED | active | — |
| DAPSONE ORAL SOLID
ORDINARY
TABLETS | 🇺🇬Uganda | GITTOES PHARMACEUTICA LS LIMITED | active | — |
| DAPSONE ORAL SOLID
ORDINARY TABLETS | 🇺🇬Uganda | GITTOES PHARMACEUTICA LS LIMITED | active | — |
DAPSONE in Africa — Regulatory Overview
DAPSONE is registered across 3 African markets with 7 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Uganda, South Africa, WW. AfricaRegulatory refreshes this data daily from official government sources.
Of the 7 registrations, 7 (100%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.